Yesterday | Dermatology Times
Just say 'no': Drug interactions must be evaluated before dermatologic procedures
Many elderly patients who take numerous medications, including anticoagulants such as Plavix , Coumadin or aspirin, experience pre-, peri- and post-op surgical bruising.
India angered by EU generic drug seizure
NEW DELHI: India accused the European Union on Wednesday of violating WTO norms by confiscating generic drugs made by Indian pharmaceutical companies, a report said.
How safe are popular reflux drugs?
Millions of Americans take drugs like Nexium, Prevacid and Prilosec to ease the erosive effects of acid reflux, but do these medicines put patients at risk for other health problems? Experts remain divided on the potential dangers these common prescription medications might pose.
Cleveland Clinic Journal of Medicine
Dual-antiplatelet therapy: A case-based approach
EDUCATIONAL OBJECTIVE: Readers will appreciate different applications of dual antiplatelet therapy in day-to-day practice Dual antiplatelet therapy in coronary artery disease: A case-based approach VENU MENON , MD ADDRESS: Venu Menon, MD, Coronary Care Unit, Cardiovascular Institute, J1-5, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; ...
Heart patients who show mutation are unlikely to benefit from common anti-clotting drug - Nelvin C. Cepeda / Union-Tribune IS PLAVIX RIGHT FOR YOU? A new genetic test identifies people who likely won't benefit from taking Plavix, a common anti-clotting drug, after having a stent placed in an artery.
Optimizing Antiplatelet Therapy in High-Risk Patients With Atrial...
Optimizing Antiplatelet Therapy in High-Risk Patients With Atrial Fibrillation. Insights From Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events Raymond Chee-Seong Seet MD* and Christopher P.L. Chen MD From the Departments of Medicine and Pharmacology , Yong Loo Lin School of Medicine, National University ...
New hope on finding better blood thinners
Problems with warfarin are the most common reason for emergency-room visits by older adults, according to the Centers for Disease Control and Prevention.
Pharmacogenetics and Stroke [Topical Review]
Correspondence to James F. Meschia, MD, Mayo Clinic, 4500 San Pablo Rd, Jacksonville, FL 32224.
Comparative Effectiveness Research: One way to beat the competition
A higher percentage of companies are using Comparative Effectiveness Research to help with pricing and reimbursement decisions, according to new research from Cutting Edge Information.
Medco Launches Plavix(R), Effient(R) Comparative Effectiveness Study Examining Role Of Genetics
Medco Health Solutions, Inc. announced it will conduct a head-to-head study of Plavix and Effient that measures how the effectiveness of these drugs in heart patients is impacted by their genetic make-up. The study will examine whether the 70 to 75 percent of patients who are "extensive metabolizers" of clopidogrel - because they were born with a ...
New hope on finding better blood thinners
Warfarin, one of the most inconvenient, dangerous, and disliked drugs in the world, has remained vitally important for more than 50 years.
Medco plans to compare Plavix, Effient in study
Medco Health Solutions Inc. said Tuesday it will compare the blood thinner Plavix, the world's second-best selling drug, with the newer Effient to study.
Fish Oil Deemed Safe for Antiplatelet Therapy Patients
In patients with cardiovascular disease, the bleeding risk is not increased when high-dose fish oil is combined with aspirin and clopidogrel, according to a study in the Oct.
Research and Markets: Stroke: Treatments and Prescribing Practices - A Global Survey 2009 Report
This report presents the findings of a global survey on current treatments and prescribing practices for Ischaemic Stroke, Haemorrhagic Stroke and Transient Ischaemic Attack .
Scripps offering genetic testing for stent patients
Scripps Health is offering genetic testing to cardiovascular patients planning to undergo elective stent procedures to open clogged heart arteries.
Cilostazol, a phosphodiesterase inhibitor, attenuates photothrombotic ...
Correspondence: Dr H Ito, First Institute of New Drug Discovery, Otsuka Pharmaceutical Co.
IMS Health forecasts growth in U.S., global pharmaceutical markets
NORWALK, Conn. Strong near-term growth in the U.S. pharmaceutical market will drive growth in the global pharmaceutical market, according to a forecast by market research firm IMS Health.
Quest Diagnostics Brings Genetic Testing For Plavix(R) Response To...
DNA testing for gene variants that can increase the risk of major coronary events in certain patients taking the anti-clotting drug Plavix is now being performed by Quest Diagnostics for Scripps Health patients electing to undergo coronary stent procedures.
Test detects patients who don't respond to Plavix
"Just spit." With those simple instructions, health care providers in California are hoping to expand the use of genetic testing to make sure patients get the right medication.
New oral thrombin inhibitor dabigatran has advantages over warfarin in atrial fibrillation
From the NEJM : Dabigatran is a new oral direct thrombin inhibitor. In patients with atrial fibrillation , dabigatran 110 mg po bid was associated with rates of stroke and systemic embolism that were similar to those associated with warfarin, as well as lower rates of major hemorrhage.
Also on Topix